AstraZeneca buys Almirall lung drugs for up to $2.1 billion

Written by Editor
Published in News Feeds

LONDON (Reuters) - AstraZeneca took a major step to build up its respiratory medicine business on Wednesday by striking a deal worth up to $2.1 billion (1.24 billion pounds) for the rights to Spanish group Almirall's lung drugs.

Read more http://uk.reuters.com/article/2014/07/30/uk-astrazeneca-almirall-idUKKBN0FZ0E320140730?feedType=RSS&feedName=topNews

Action Sports

AstraZeneca buys Almirall lung drugs for up to $2.1 billion

Students less focused, empathic and active than before – technology may be to blame

Insight- Millennials' 20 Most Engaging Brands

Poll wrap: Worst reaction to midterm PM change in Newspoll history; contrary polls in Dutton's Dickson

We need to stop innovating in Indigenous housing and get on with Closing the Gap

As weary Britons head to the polls again, parties seem incapable of handling the nation's problems

COVID-19 increases risk to international students' mental health. Australia urgently needs to step up

Ibuprofen might make your periods lighter, but it's not a long-term solution

Lessons in resilience: what city planners can learn from Hobart's floods

Business Travel Show buyer survey results

Australia could house around 900,000 more migrants if we no longer let in tourists

Was New Zealand's coronavirus lockdown legal? One week might make all the difference